COVID-19 and Bradyarrhythmias: A Case Report With Literature Review

Ansari, Saad Ali; Ansari, Yusra; Khan, Tahir

doi:10.7759/cureus.21552

Cited by 3 publications

(5 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with hemodynamically stable SA, the consideration of additional pacemaker therapy is warranted in patients with overt symptomatic SA [8]. Te efcacy of permanent pacemaker implantation in improving SA in patients with COVID-19 infection has been described in some reports [22][23][24][25], while the utilization of temporary pacemakers has also been reported [4,26]. However, in this case, due to the patient's long-term impairment of consciousness, even if the SA episode presented with symptoms, she was unable to articulate them.…”

Section: Discussionmentioning

confidence: 99%

“…It is worth noting that the duration of SA in our patient, from onset to disappearance (14 days), was comparable to that observed in these two cases. Ansari et al [ 4 ] demonstrated that the average age of COVID-19 patients with bradyarrhythmia was 56.3 ± 15.2 years old. Although there have been reports of transient SA in patients as young as 83 years old [ 18 ], the majority of cases have been observed in younger individuals.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, it can give rise to circulatory ischemia, a life-threatening condition [ 3 ]. The current evidence suggests that SA can be secondary to COVID-19 infection; for example, the study conducted by Ansari et al [ 4 ] reviewed 30 case reports/case series involving 67 patients with bradyarrhythmias in COVID-19 infection, revealing that SA was observed in 17.9% of the patients.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Infection with COVID-19 Complicated by Sinus Arrest

Zhang,

He,

Lin

et al. 2024

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

As a respiratory tract-transmitted disease, coronavirus disease 2019 (COVID-19) exerts a profound immune injury effect, leading not only to pulmonary impairment but also to cardiac complications. We present a case of a 79-year-old woman, who had previously contracted COVID-19 and subsequently developed sinus arrest (SA) following her second infection. The longest asystole time detected by Holter monitoring was 7.2 seconds. Although the patient met criteria for permanent pacemaker implantation, her family declined this intervention and conservative management was pursued instead. However, after a period of observation, the patient’s SA resolved. The present case study describes a patient who experienced SA upon reinfection with COVID-19, which was not present during the initial infection. It emphasizes the impact of COVID-19 on cardiac health, particularly its potential to induce arrhythmias. In addition, it is worth noting that the arrhythmia induced by a COVID-19 infection may show reversibility, suggesting that a permanent pacemaker might not be the priority option if further pacing therapy is being considered.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Infection with COVID-19 Complicated by Sinus Arrest

Zhang,

He,

Lin

et al. 2024

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…This decision was made based on the identification of COVID-19 as a transient trigger. In contrast, permanent pacemakers have been placed in some COVID-19 patients presenting with or without syncope (10)(11)(12). In patients with more than one type of bradyarrhythmia, such as complete heart block, sinus bradycardia, sinus arrest, second-degree atrioventricular (AV) block, or high AV block, 30% eventually required a permanent pacemaker (12).…”

Section: Discussionmentioning

confidence: 99%

Repeated Syncope Following COVID-19 Infection

Arita,

Takaki,

Suetani

et al. 2024

Intern. Med.

View full text Add to dashboard Cite

A 74-year-old woman presented to our hospital with syncope after a coronavirus disease 2019 (COVID-19) infection. Upon admission, she passed out, and an 8-second sinus arrest was detected during telemetry monitoring. During the next syncope episode, telemetry monitoring showed that her heart rate decreased from 80 to 36 bpm, accompanied by a 2.4-second pause. A permanent pacemaker was implanted; however, the patient still experienced syncope. The head-up tilt test revealed a vasodepressor reflex syncope. The need for permanent pacemakers in patients with syncope following COVID-19 therefore remains controversial.

show abstract

“…In the wake of the global COVID-19 pandemic, medical professionals have been faced with an ever-evolving landscape of symptoms and complications associated with the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus [1]. While respiratory distress and pneumonia have been at the forefront of clinical attention, it has become increasingly evident that COVID-19 can affect multiple organ systems, leading to a wide array of clinical manifestations [2][3][4][5]. One such manifestation that has emerged as an intriguing and potentially life-threatening complication is bradycardia, a condition characterized by an abnormally slow heart rate.…”

Section: Introductionmentioning

confidence: 99%

A Slow Beat and a Dizzying Feat: COVID-19 Related Bradyarrhythmia

Chowdhury,

Sajeev,

Dey

et al. 2023

JAMMR

View full text Add to dashboard Cite

Coronavirus disease (COVID-19) was formerly thought to be a respiratory ailment, however it has since been discovered to have an impact on practically all organ systems. Bradycardia is a recently identified COVID-19 ramification with uncertain prognostic significance. To the best of our knowledge, very few case reports have been reported on marked bradycardia as a complication of Covid-19 infection. Studies have revealed a higher risk of mortality in individuals with underlying cardiovascular disease as well as an increase in the prevalence of arrhythmias, cardiomyopathies, myocarditis, and acute coronary syndromes in infected patients. We report a case of a 72 year old male patient who exhibited persistent bradycardia following COVID-19 infection resulting in significant dizziness as a symptom. Clinicians should be aware of the mechanism by which COVID-19 affects the cardiovascular system and the drug side effects that are used in the treatment strategy for this fatal virus, even if the pathophysiology of bradycardia in COVID-19 may be multifactorial. A thorough review examining bradyarrhythmia and relative bradycardia in COVID-19-infected patients has not yet been published.

show abstract

COVID-19 and Bradyarrhythmias: A Case Report With Literature Review

Cited by 3 publications

References 34 publications

Infection with COVID-19 Complicated by Sinus Arrest

Infection with COVID-19 Complicated by Sinus Arrest

Repeated Syncope Following COVID-19 Infection

A Slow Beat and a Dizzying Feat: COVID-19 Related Bradyarrhythmia

Contact Info

Product

Resources

About